Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study
| dc.contributor.author | Hyams, D. | |
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | de Oliveira, C. | |
| dc.contributor.author | Snyder, R. | |
| dc.contributor.author | Vinholes, J. | |
| dc.contributor.author | Audeh, M W. | |
| dc.contributor.author | Alencar, V. | |
| dc.contributor.author | Lombard, J. | |
| dc.contributor.author | Mookerjee, B. | |
| dc.contributor.author | Xu, J. | |
| dc.contributor.author | Brown, K. | |
| dc.contributor.author | Klein, P. | |
| dc.date.accessioned | 2017-01-30T13:40:11Z | |
| dc.date.available | 2017-01-30T13:40:11Z | |
| dc.date.created | 2014-11-19T01:13:19Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Hyams, D. and Chan, A. and de Oliveira, C. and Snyder, R. and Vinholes, J. and Audeh, M W. and Alencar, V. et al. 2013. Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study. Investigational New Drugs. 31 (5): pp. 1345-1354. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/33934 | |
| dc.publisher | Springer Science + Business Media | |
| dc.title | Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study | |
| dc.type | Journal Article | |
| dcterms.source.volume | 31 | |
| dcterms.source.number | 5 | |
| dcterms.source.startPage | 1345 | |
| dcterms.source.endPage | 1354 | |
| dcterms.source.issn | 01676997 | |
| dcterms.source.title | Investigational New Drugs | |
| curtin.accessStatus | Fulltext not available |